Overview
Rybelsus 3 mg contains Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used for managing type 2 diabetes mellitus in adults. This oral medication works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying, helping to lower blood sugar levels. The 3 mg dose is intended as a starting dose to initiate treatment and minimize gastrointestinal side effects before progressing to higher doses.





